{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:30:18Z","timestamp":1793053818557,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T00:00:00Z","timestamp":1751500800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The impact of the intratumoral microbiome (ITM) on the treatment and prognosis of gastric cancer (GC) remains controversial. Our study analyzed the differential ITM in GC tissues and identified nine bacterial genera significantly associated with overall survival (OS), with seven as risk factors and two as protective factors. Three distinct clusters with varying survival outcomes were defined, demonstrating correlations with pathological stage and immune features. An immune-related gene-based RiskScore model incorporating genes such as Apolipoprotein D (APOD), Stanniocalcin 1 (STC1), Coagulation Factor II Thrombin Receptor (F2R), Angiotensinogen (AGT), Fatty Acid Binding Protein 4 (FABP4), Inhibin Subunit Beta A (INHBA), Caspase Recruitment Domain Family Member 11 (CARD11), and Dickkopf WNT Signaling Pathway Inhibitor 1 (DKK1) was established and validated in The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets. When combined with clinical factors, this RiskScore model formed a Nomogram model achieving Areas Under the Curve (AUCs) of 0.72, 0.76, and 0.79 for 1, 3, and 5-year OS predictions, respectively. This model exhibited robust predictive accuracy over time and correlated with mutation frequency, drug sensitivity, and immunotherapy response. Furthermore, single-cell analysis revealed that tumor-associated fibroblasts may play a pivotal role in immune-microbial interactions. The results were confirmed using quantitative real-time polymerase chain reaction (qPCR) and immunohistochemistry (IHC). In conclusion, the prognostic model incorporating ITM and immune-related genes aids in risk stratification and provides valuable insights and targets for GC treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1622959","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T01:26:55Z","timestamp":1751506015000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Peng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchao","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"Ca-Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5114\/pg.2018.80001","article-title":"Epidemiology of gastric cancer: global trends, risk factors and prevention","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074937","article-title":"The microbiome in infectious disease and inflammation","volume":"30","author":"Honda","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.44","article-title":"Anticancer effects of the microbiome and its products","volume":"15","author":"Zitvogel","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology."},{"key":"B10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1053\/j.gastro.2015.09.004","article-title":"Pathobiology of helicobacter pylori-induced gastric cancer","volume":"150","author":"Amieva","year":"2016","journal-title":"Gastroenterology."},{"key":"B11","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2024.01.004","article-title":"Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice","volume":"187","author":"Fu","year":"2024","journal-title":"Cell."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-021-01202-8","article-title":"Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4\/PI3K\/Akt signaling","volume":"24","author":"Li","year":"2021","journal-title":"Gastric C"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15781","article-title":"Fusobacterium nucleatum-induced exosomal HOTTIP promotes gastric cancer progression through the microRNA-885-3p\/EphB2 axis","volume":"114","author":"Xin","year":"2023","journal-title":"Cancer Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e000435","DOI":"10.1136\/jitc-2019-000435","article-title":"Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients","volume":"8","author":"Rockinger","year":"2020","journal-title":"J Immunother Cancer."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor mutational load predicts survival after immunotherapy across multiple cancer types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.cell.2022.02.027","article-title":"Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer","volume":"185","author":"Fu","year":"2023","journal-title":"Cell."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-22-2593","article-title":"Intratumoral microbiota composition regulates chemoimmunotherapy response in esophageal squamous cell carcinoma","volume":"83","author":"Wu","year":"2023","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2369336","article-title":"Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy","volume":"16","author":"Wang","year":"2024","journal-title":"Gut Microbes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12967-023-04582-w","article-title":"Leveraging circulating microbiome signatures to predict tumor immune microenvironment and prognosis of patients with non-small cell lung cancer","volume":"21","author":"Zhou","year":"2023","journal-title":"J Transl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00859-1","article-title":"Dendritic cells as orchestrators of anticancer immunity and immunotherapy","volume":"21","author":"Heras-Murillo","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Cancer Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13045-017-0408-0","article-title":"Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein","volume":"10","author":"Chen","year":"2017","journal-title":"J Hematol Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","article-title":"Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression","volume":"23","author":"Deng","year":"2023","journal-title":"Mol Cancer."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.ccell.2022.09.009","article-title":"Tumor microbiome links cellular programs and immunity in pancreatic cancer","volume":"40","author":"Ghaddar","year":"2022","journal-title":"Cancer Cell"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1038\/s41467-022-30512-3","article-title":"Predicting cancer prognosis and drug response from the tumor microbiome","volume":"13","author":"Hermida","year":"2022","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Cancer Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6918","article-title":"The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies","volume":"359","author":"Zitvogel","year":"2018","journal-title":"Science."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21398","article-title":"The role of the microbiome in cancer development and therapy","volume":"67","author":"Bhatt","year":"2017","journal-title":"Ca-Cancer J Clin"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00951-0","article-title":"Role of the microbiota in response to and recovery from cancer therapy","volume":"24","author":"Blake","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05435-0","article-title":"Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer","volume":"611","author":"Ni\u00f1o","year":"2022","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-022-01304-4","article-title":"Intratumoral microbiota: roles in cancer initiation, development and therapeutic efficacy","volume":"8","author":"Yang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5415.770","article-title":"Notch signaling: cell fate control and signal integration in development","volume":"284","author":"Artavanis-Tsakonas","year":"1999","journal-title":"Science."}],"updated-by":[{"DOI":"10.3389\/fimmu.2025.1670563","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622959\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:23:08Z","timestamp":1754986988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1622959\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,3]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2025.1622959"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1622959","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2025.1670563","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,3]]},"article-number":"1622959"}}